"
Team:HKU HongKong/Data/Weekly Notebook.html
From 2012.igem.org
(Difference between revisions)
| Line 516: | Line 516: | ||
</font></p> | </font></p> | ||
| - | <font face="Trebuchet MS" size="4">Weeks 3:</font></span></h2> | + | <div align="left"><font face="Trebuchet MS" size="4">Weeks 3:</font></span></h2> |
| - | <br> | + | <br> |
| - | <font face-"trebuchet MS" size="3">28/07/2012<font></span></h2> | + | <font face-"trebuchet MS" size="3">28/07/2012<font></span></h2> |
| - | <br> | + | <br> |
| - | 1)</span><span style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none; "> | + | 1)</span><span style="color: rgb(35, 35, 35); font-family: Lato, Tahoma, Arial, sans-serif; font-size: 13px; font-style: normal; font-variant: normal; font-weight: normal; letter-spacing: normal; line-height: 19.5px; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-size-adjust: auto; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); display: inline !important; float: none; "> |
| - | </span><font face="Tahoma" size="2"><b> | + | </span><font face="Tahoma" size="2"><b>Transform J23119 (constitutive promoter) and B0034 (Ribosomal Binding Site) from the kit. </b></font><br> |
| + | <br> | ||
| + | <br> | ||
| + | </div> | ||
</body> | </body> | ||
</html> | </html> | ||
Revision as of 02:04, 27 September 2012
Team:HKU HK
From 2011.igem.org
Daily Lab Notebook
Weeks 1&2:
1)
Amplification of pvdQ gene using PCR from Pseudomonas aeuriginosa genomic DNA. The designed primers contain the prefix and suffix so that typical digestion for insertion into iGEM’s standard vector can be subsequently performed.
2)Test digestion of amplified pvdQ with EcoRI only, EcoRI & SpeI, PstI, and EcoRI & XbaI.
3) Repeat the digestion of pvdQ with EcoRI and SpeI multiple times to obtain the desirable conditions of the digestion to prevent Star Activity.
4)Mass single digestion of the amplified pvdQ with EcoRI. Desirable fragment size should be about 5,600bp. The fragments that result due to Star activity are 3,800 and 1,800bp.
5)Gel purification and Nano-drop concentration check of digested pvdQ.
Weeks 3:
28/07/2012
1) Transform J23119 (constitutive promoter) and B0034 (Ribosomal Binding Site) from the kit.
28/07/2012
1) Transform J23119 (constitutive promoter) and B0034 (Ribosomal Binding Site) from the kit.
